|
CHSY1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.869700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.434500E-02 |
| Normal-vs-Stage2 |
1.068030E-02 |
| Normal-vs-Stage3 |
2.662600E-01 |
| Normal-vs-Stage4 |
5.207800E-01 |
| Stage1-vs-Stage2 |
1.996760E-01 |
| Stage1-vs-Stage3 |
9.887000E-01 |
| Stage1-vs-Stage4 |
9.433800E-01 |
| Stage2-vs-Stage3 |
4.117200E-01 |
| Stage2-vs-Stage4 |
5.434000E-01 |
| Stage3-vs-Stage4 |
9.436800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.622200E-02 |
| Normal-vs-AfricanAmerican |
1.725150E-01 |
| Normal-vs-Asian |
1.374430E-01 |
| Caucasian-vs-AfricanAmerican |
6.609200E-01 |
| Caucasian-vs-Asian |
7.063400E-01 |
| AfricanAmerican-vs-Asian |
5.631600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.085500E-02 |
| Normal-vs-Female |
7.252600E-01 |
| Male-vs-Female |
2.692400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.148400E-02 |
| Normal-vs-Extreme_Weight |
1.462160E-01 |
| Normal-vs-Obese |
9.738000E-02 |
| Normal-vs-Extreme_Obese |
9.010100E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.279200E-01 |
| Normal_Weight-vs-Obese |
6.597200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.842200E-01 |
| Extreme_Weight-vs-Obese |
8.756200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.016000E-01 |
| Obese-vs-Extreme_Obese |
6.539600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.916400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.530600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.382300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.429200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.267570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.847000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.067500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.385990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.811200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.676900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.394800E-01 |
| Normal-VS-Type2 PRCC |
1.93110000001884E-06 |
| Normal-VS-KIRP CIMP |
8.777000E-01 |
| Normal-VS-Unclassified PRCC |
4.504100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.36369999970532E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.789600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.191360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.058990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.690240E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.301400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.735600E-03 |
| Normal-vs-N1 |
1.698030E-02 |
| Normal-vs-N2 |
7.836800E-01 |
| N0-vs-N1 |
7.161400E-01 |
| N0-vs-N2 |
4.446200E-01 |
| N1-vs-N2 |
4.838600E-01 |
|
|
